Table 2.
Comparison of pathologies in cognitively normal individuals and cognitively impaired individuals
Cognitively normal (CDR = 0; n = 79) | Cognitively impaired (CDR ≥ 0.5; n = 625) | p value | |
---|---|---|---|
ADNC, Int-High | 27 (34.2%) | 435 (69.6%) | <0.0001 |
LATE-NC, stages 2–3 | 11 (13.9%) | 204 (32.6%) | 0.0004 |
LBD, stages 2–3 | 17 (21.5%) | 146 (23.4%) | 0.7785 |
Cerebrovascular disease | 39 (43.8%) | 289 (46.2%) | 0.6331 |
At least 1 proteinopathy | 44 (55.7%) | 530 (84.8%) | <0.0001 |
Multiple proteinopathies | 13 (16.5%) | 221 (35.4%) | 0.0006 |
At least 1 pathology | 46 (58.2%) | 541 (86.6%) | 0.0208 |
Multiple pathologies | 15 (19.0%) | 260 (41.6%) | <0.0001 |